Search clinical trials for: TP2

Total 1639 results

Hamilton Health Sciences Corporation

Completed

Warfarin After Anterior ST-Elevation Myocardial Infarction

Myocardial Infarction

Canada
Kafrelsheikh University

Recruiting

Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke

Ischemic Stroke

Egypt
The 476th Hospital of People's Liberation Army

Unknown

Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis

Intracranial Atherosclerosis
Northwestern University

Completed

Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events

Stroke | Myocardial Infarctions

United States
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Unknown

Role of Immune Responses After Acute Myocardial Infarction (BATTLE-AMI)

Myocardial Fibrosis

Brazil
Ahmad Slim
Bristol-Myers Squibb

Terminated

Aspirin and Plavix Following Coronary Artery Bypass Grafting (ASAP-CABG)

Coronary Graft Patency

United States
AstraZeneca

Completed

Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

Korea, Republic of, Japan, Taiwan
Eli Lilly and Company
Duke Clinical Research Institute; Daiichi Sankyo Co., Ltd.

Completed

A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects (TRILOGY ACS)

Acute Coronary Syndrome

Argentina, Brazil, Canada, Italy, China, Puerto Rico, Australia, Romania, Russian Federation, France, Germany, United States, Belgium, Bulgaria, Poland, Ukraine, United Kingdom, Colombia, Hungary, Philippines, Croatia, Denmark, India, Chil... and more
Estetra

Completed

Cycle Control Assessment of a Combined Oral Contraceptive Containing Estetrol and a Progestin P1 or P2 (FIESTA)

Contraception

Finland
Chong Kun Dang Pharmaceutical
Inje University

Completed

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination

Coronary Artery Disease

Korea, Republic of
US Department of Veterans Affairs
Bristol-Myers Squibb; Sanofi-Synthelabo

Completed

Warfarin and Antiplatelet Therapy in Chronic Heart Failure

Heart Failure

United States, Canada, United Kingdom
National Institute of Neurological Disorders and...

Completed

Antiplatelet Therapy to Prevent Stroke in African Americans

Stroke | Cerebral Infarction

United States
St. Jude Children's Research Hospital

Completed

Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma

Hodgkin's Lymphoma

United States
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Not yet recruiting

Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin Combined With Half-dose Ticagrelor in Patients With Unruptured Intracranial Aneurysms With Normal CYP2C19 Metabolizer Phenotype

Intracranial Aneurysms | Antiplatelet Drugs
Beijing Tiantan Hospital

Not yet recruiting

Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke (TAPIS)

Ischemic Stroke, Acute
Kafrelsheikh University

Recruiting

Clopidogrel Versus Cilostazol in Ischemic Stroke

Ischemic Stroke

Egypt
Peking Union Medical College Hospital
Pharmaron (Chengdu) Clinical Services Co., Ltd.

Recruiting

Efficacy and Safety of Tirofiban for Patients With BAD (BRANT) (BRANT)

Branch Atheromatous Disease

China
Samsung Medical Center

Terminated

P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold (SMART-CHOICEII)

Coronary Artery Disease | Atherosclerosis | Stents

Korea, Republic of
Second Affiliated Hospital, School of Medicine,...

Completed

Ticagrelor Versus Clopidogrel for CMD in Patients With AMI: A Retrospective Study Based on the Angio-IMR

Coronary Heart Disease

China
University of Arkansas
American Society of Nephrology

Completed

Chronic Kidney Disease (CKD) Platelet Study

Chronic Kidney Diseases | Stroke, Ischemic | Heart Attack

United States
University of Alberta

Withdrawn

The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack (MENA-TIA)

Transient Ischemic Attacks | Minor Stroke

Canada
University Hospital, Bordeaux

Completed

Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI) (TICTAVI)

Aortic Valve Stenosis

France
University of Athens

Completed

A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI (PTOLEMAIOS)

Aortic Valve Stenosis

Greece
University of Florida
Merck Sharp & Dohme LLC

Completed

Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor (VORA-PRATIC)

Myocardial Infarction

United States
Andres Iñiguez Romo, MD, PhD

Completed

Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI (AUREA)

Stroke | Aortic Valve Stenosis

Spain
Collegium Medicum w Bydgoszczy

Completed

Influence of Metoclopramide on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine

Unstable Angina Pectoris

Poland
Bayer

Completed

Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN) (EPISAT)

Stroke | Coronary Heart Disease | Ischemic Heart Disease | Secondary Prevention

United Kingdom
Juan J Badimon
AstraZeneca

Completed

Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients

Coronary Artery Disease | Type-2 Diabetes Mellitus

United States
Shahid Beheshti University of Medical Sciences

Unknown

Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator

Venous Occlusion | Complication of Cardiac Defibrillator | Disorder of Cardiac Pacemaker System

Iran, Islamic Republic of
RenJi Hospital

Unknown

Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI

Acute Coronary Syndrome

China
University of Calgary
Canadian Institutes of Health Research (CIHR); Canadian Stroke Consortium (CSC)

Completed

Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)

Stroke | Transient Ischemic Attack

United States, Canada
Hoffmann-La Roche

Active, not recruiting

A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis (Ocarina II)

Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis

Spain, United States, Italy, Poland, Turkey, New Zealand, Czechia, Brazil
Kafrelsheikh University

Recruiting

Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke

Ischemic Stroke

Egypt
University of Florida

Recruiting

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI (TAILOR BLEED)

Coronary Artery Disease

United States
Assistance Publique - Hôpitaux de Paris
Fonds de Dotation ACTION

Not yet recruiting

Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome (ADEN)

MYOCARDIAL INFARCTION

France
McGill University Health Centre/Research Institute...
Canadian Institutes of Health Research (CIHR)

Completed

Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes (TC4)

Acute Coronary Syndrome

Canada
Jiangsu HengRui Medicine Co., Ltd.

Completed

To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects

Thrombosis

China
Beijing Neurosurgical Institute

Completed

Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms (APISIA Trail)

Stents | Unruptured Intracranial Aneurysm | Antiplatelet Drugs

China
Beijing Tiantan Hospital
University of California, San Francisco

Completed

Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events (CHANCE)

Stroke | Transient Ischemic Attack

China
IlDong Pharmaceutical Co Ltd
Asan Medical Center

Terminated

Safety Study of APD-791 With Aspirin and/or Clopidogrel (TG1C)

Acute Coronary Syndrome
University of Sao Paulo General Hospital
InCor Heart Institute

Completed

Ranitidin Versus Omeprazole in Patients Taking Clopidogrel

Coronary Artery Disease | Drug Interaction Potentiation
Jeil Pharmaceutical Co., Ltd.

Completed

Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent

ANEURYSM CORONARY ARTERY
Radboud University Medical Center

Completed

Ticagrelor in Human Endotoxemia Response to Human Endotoxemia

Endotoxemia

Netherlands
Asan Medical Center
Korea Otsuka International Asia Arab

Completed

Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II (TOSS-2)

Atherosclerosis | Cerebral Infarction

Philippines, Korea, Republic of, Thailand, Hong Kong
Yale University
American Heart Association

Completed

Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects

Healthy Subjects

United States
Seoul National University Bundang Hospital
Seoul St. Mary's Hospital; Asan Medical Center; Seoul National University Hospital and other collaborators

Recruiting

Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling

Endovascular Procedures | Aneurysm Cerebral

Korea, Republic of
Second Affiliated Hospital, School of Medicine,...

Recruiting

Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention (MATE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

China
Peking Union Medical College Hospital

Recruiting

Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention (APLABE-PCI)

Coronary Artery Disease | Percutaneous Coronary Intervention

China
Medical University of South Carolina

Recruiting

Pembrolizumab in Combination With Anti-platelet Therapy for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Head and Neck Cancer

United States
Yonsei University

Recruiting

Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Acute Coronary Syndrome

Korea, Republic of

Search clinical trials for: TP2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations